Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Immunological Implications and Molecular Diagnostics of Genitourinary Cancer provides an update of recent accomplishments, unifying concepts, and future challenges to study tumor-associated immune cells, with an emphasis on genitourinary cancers.
The presence of inflammatory immune cells in human tumors raises a fundamental question in oncology: How do cancer cells avoid the destruction by immune attack? In principle, tumor development can be controlled by cytotoxic innate and adaptive immune cells; however, as the tumor develops from neoplastic tissue to clinically detectable tumors, cancer cells evolve different mechanisms that mimic peripheral immune tolerance in order to avoid tumoricidal attack. Focusing on an interdisciplinary audience of immunologists, molecular biologists, virologist and cancer researchers.
Immunological Implications and Molecular Diagnostics of Genitourinary Cancer covers the shortage in the research of the immunological implications of genitourinary cancer and bridges the gap for a comprehensive view of cancers especially the genitourinary cancers diagnosis, cellular mechanism and therapy.
- discusses the impact of the immune system on the initiation, progression and treatment of cancer
- provides insight in the important role of the suppressor genes and oncogenes in genitourinary cancers
- shows the advantages of combining clinical issues of urologic cancers with immunological techniques, like immunohistochemistry and immunofluorescence
- proofs the implications genitourinary cancer has on the human innate immune system
Researchers in immunological and molecular characterization and implications of genitourinary cancer, immunologists, molecular biologists, oncologist, applied microbiologists. Students in immunology, molecular biology and cancers, oncology, virology and metabolism research
- Gene suppressor and oncogenes
2. Implication of growth factor's genes in genitourinary cancers
3. Cytokines genes alterations
4. Proteomic analysis
5. Genetic diagnostics and prognostic biomarkers
6. Exosomes as diagnostic and prognostic tool
7. Metabolism defects
8. Clinical genomic relevance
9. Recent advances of immunotherapy
10. Modern therapeutic targets
- No. of pages:
- © Academic Press 2022
- 1st May 2022
- Academic Press
- Paperback ISBN:
Dr. Moulay Mustapha Ennaji, Professor in Virology and Oncology at the University of Casablanca and Director of the Quality and Medical Biotechnologies Team at Laboratory of Virology Microbiology, Quality, Biotechnologies/Eco-Toxicology and Biodiversity, Faculty of Sciences and Techniques, Hassan II University Mohammedia of Casablanca, Morocco Prof. Dr. Moulay Mustapha Ennaji is a Moroccan and Canadian citizen and native of Marrakesh (Morocco). He is a scientist specializing in the fields of virology, hygiene, and microbiology and currently a Professor in Virology and Oncology at the University of Casablanca, and Since 2010, he has been the Director of the Quality and Medical Biotechnologies Team at the Laboratory of Virology Microbiology, Quality, Biotechnologies. He leads the Virology Oncology and Medical Biotechnology Team is and Deputy Director of the Research Centre of Natural Resources and Food (rensa) of UH2C. He has also been responsible for the master programs in biotechnology and biomedical technologies (2003), DESA of Microbiology and Bioengineering (2005-2010), Masters of Science and Technology in Microbiology, Applied Virology and Bio-industry Engineering, and MST of Livings in Immuno-Virology and Applied Microbiology (2010 to 2015). He received a MSc in 1986 and a PhD in virology in 1993 from Armand Frappier Institute, University of Quebec (Canada). Between 1991 and 1993 he completed a post doctorate at the Canadian Red Cross. From 1993 to 1995, he was a research associate (RA) and from 1995 to 1996 and a research officer (RO) at the National Council of Research of Canada (CNRC). He was also a visiting researcher at the University of California, Irvine in the United States and a lecturer at the Histochemistry Institutes of Paris (France). He was a guest researcher of the Franklin AU:1 Foundation in USA NIH Bethesda. He has published 61 journals articles and is an editorial board member of the journal, Infectious Agents and Cancer. As a scientist concerned with research development, he had been given numerous lectures in virology, cancerology, hygiene, and microbiology since 1986 at many Moroccan, Canadian, and American universities. Throughout his career, Dr. Ennaji has been rewarded 24 awards. He has organized numerous national and international meetings in the fields of virology, microbiology, and hygiene. At present, he is the vice president of the three Moroccan societies of Biosafety, Cancer, and Microbiology.
Professor, Virology and Oncology, University of Casablanca, Morocco; Director, Quality and Medical Biotechnologies Team, Laboratory of Virology Microbiology, Quality, Biotechnologies/Eco-Toxicology and Biodiversity; Faculty, Sciences and Techniques, Hassan II University Mohammedia of Casablanca, Morocco
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.